Thomson Reuters Micromedex solutions deliver evidence-based referential content for medication management, disease and condition management, toxicology, and patient education. Learn more >
Thomson Reuters Clinical Xpert solutions give clinicians real-time access to patient data to support clinical surveillance, patient rounding, medication reconciliation, and clinical care coordination. Learn more >
Meaningful Use With Thomson Reuters
Thomson Reuters is strongly positioned to help support hospitals and hospital system vendors meet "meaningful use" requirements. With solutions like our UltiMedex Suite, drug-drug and drug-allergy checkers, evidence-based order sets, and the Clinical Xpert Suite of solutions (Navigator, Handoff, CareFocus, and Medication Reconciliation), Thomson Reuters is helping customers today to address these critical clinical requirements. We are closely monitoring the development of meaningful use criteria and will proceed with product certification where appropriate as the criteria for meaningful use are finalized.
Learn more about these solutions:
Micromedex News & Updates
Sign up to receive the Thomson Reuters Micromedex News & Updates email newsletter. You'll receive healthcare stories that impact you directly – delivered right to your inbox! Plus, you'll get the latest news on Thomson Reuters product launches, enhancements, and tips to help maximize your subscription.
Micromedex Healthcare Evidence - Mobile Solution
Current Healthcare Series Customers & Students: Download the Healthcare Evidence - Mobile Solution for free. Learn More >
CDS BEST PRACTICES BRIEF
It's likely your organization is investing heavily to address performance improvement imperatives and challenges. Embedding knowledge and intelligently filtered patient data into clinical workflow-that is, providing clinical decision support (CDS)-is a critical success factor. CDS can be a powerful tool to arm clinicians and patients with the right information to ensure care processes that should always happen-always do, and those that never should-don't. Thomson Reuters solutions and expertise can help you ensure success. Learn more >
ADDITIONAL INFORMATION
CAMPAIGNS
